期刊文献+

三七皂甙对局灶性脑缺血再灌注后MMP-9表达的影响 被引量:11

Effect of Panax notoginseng saponins on MMP-9 expression after focal cerebral ischemia-reperfusion
下载PDF
导出
摘要 目的探讨三七皂甙对大鼠脑缺血再灌注后基质金属蛋白酶-9(MMP-9)表达的影响。方法采用半定量RT—PCR测定MMP-9的变化,测定脑梗死体积并观察血脑屏障的破坏程度。结果再灌注后22 h,三七皂甙治疗组脑梗死体积和脑缺血区血脑屏障的破坏程度均低于对照组(P<0.05);三七皂甙治疗组MMP-9的表达明显低于对照组。结论三七皂甙能减轻脑缺血再灌注后的损伤和血脑屏障的破坏程度,抑制MMP-9的表达可能是其作用机制之一。 Objective To investigate the effect of Panax notoginseng saponins on metalloproteinase-9 ( MMP-9 ) expression after focal cerebral ischemia-reperfusion. -Methods Using intravascular thread model with 2 h occlusion and 22 h reperfusion in rats, the brain infarction size and the degree of blood-brain barrier ( BBB) disruption in the ischemic region were evaluated. MMP-9 expression was evaluated by semi-quantitative RT-PCR. Results The brain infarction volume and area of BBB disruption were dramatically decreased in treatment group as compared to control group. The level of MMP-9 mRNA in experimental group was significantly lower than control rats. Conclusion BBB disruption and ischemic injury were attenuated by Panax notoginseng saponins after focal cerebral ischemia-reperfusion, one mechanism is through its inhibition of MMP-9 expression.
出处 《上海第二医科大学学报》 CSCD 2004年第9期731-733,共3页 Acta Universitatis Medicinalis Secondae Shanghai
关键词 三七皂甙 MMP-9 表达 血脑屏障 对照组 局灶性脑缺血再灌注 脑梗死体积 对局 结论 目的 cerebral ischemia-reperfusion Panax notoginseng saponins metalloproteinase-9 blood-brain barrier
  • 相关文献

参考文献5

  • 1Fujimura M, Gasche Y, Morita-Fujimura Y, et al. Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion [ J].Brain Research 1999, 842:92 - 100.
  • 2Mayer SA, Lignelli A, Fink ME, et al. Perilesional blood flow and edema formation in acute intracerebral hemorrhage: a SPECT study[J]. Stroke, 1998, 29(9): 1 791-1 798.
  • 3del Zoppo GJ, Copeland BR, Anderchek K, et al. Hemorrhagic transformation following tissue plasminogen activator in experimental cerebral infaretion[J]. Stroke,1990, 21: 596 -601.
  • 4Levy DE, Brott TG, Haley EC, et al. Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke[ J]. Stroke, 1994,, 25:291 -297.
  • 5Montaner J, Molina CA, Monasterio J, et al. Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke [ J ]. Circulation, 2003,107(4): 598 -603.

同被引文献185

引证文献11

二级引证文献125

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部